UBS AM’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.66M | Buy |
|
|||||
|
2025
Q1 | $1.76M | Buy |
|
|||||
|
2024
Q4 | $2.22M | Buy |
|
|||||
|
2024
Q3 | $2.04M | Buy |
|
|||||
|
2024
Q2 | $902K | Buy |
|
|||||
|
2024
Q1 | $496K | Buy |
|
|||||
|
2023
Q4 | $330K | Hold |
|
|||||
|
2023
Q3 | $233K | Sell |
|
|||||
|
2023
Q2 | $601K | Hold |
|
|||||
|
2023
Q1 | $601K | Buy |
|
|||||
|
2022
Q4 | $569K | Buy |
|